home All News open_in_new Full Article

AstraZeneca invests $2.5bn to build new R&D centre in Beijing, China

AstraZeneca invests $2.5bn to build new R&D centre in Beijing, China  World Pharmaceutical Frontiers


today 46 h. ago attach_file Economics

attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics


ID: 561298430
Add Watch Country

arrow_drop_down